CSNpharm
CSNpharm
Gatifloxacin inhibits DNA gyrase and topoisomerase IV in bacterial. It is an antibiotic of the fourth-generation fluoroquinolone family.
More Information
Supplier Page
CSNpharm
Gatifloxacin inhibits DNA gyrase and topoisomerase IV in bacterial. It is an antibiotic of the fourth-generation fluoroquinolone family.
More Information
Supplier Page
CSNpharm
Gatifloxacin inhibits DNA gyrase and topoisomerase IV in bacterial. It is an antibiotic of the fourth-generation fluoroquinolone family.
More Information
Supplier Page
CSNpharm
Gatifloxacin HCl is a fourth-generation fluoroquinolone antibiotic working by inhibiting the bacterial enzymes DNA gyrase and topoisomerase IV.
More Information
Supplier Page
CSNpharm
GB-1a
1mg
| ≥98%
CSNpharm
GB-1a is a natural product isolated and purified from the leaves of Garcinia travancorica showing potential in vitro antioxidant activities.
More Information
Supplier Page
GB-1a
5mg
| ≥98%
CSNpharm
GB-1a is a natural product isolated and purified from the leaves of Garcinia travancorica showing potential in vitro antioxidant activities.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
GC376
50mg
| ≥98%
CSNpharm
GC376 is a 3CLpro (3C-like protease) inhibitor that shows promise in treating cats with certain presentations of FIP and has opened the door to targeted antiviral drug therapy.
More Information
Supplier Page
GC376
100mg
| ≥98%
CSNpharm
GC376 is a 3CLpro (3C-like protease) inhibitor that shows promise in treating cats with certain presentations of FIP and has opened the door to targeted antiviral drug therapy.
More Information
Supplier Page
CSNpharm
GDP-α-D-mannose disodium is the donor substrate for mannosyltransferases and the precursor of GDP-β-L-fucose. GDP-α-D-mannose disodium gives a competitive inhibition with respect to GTP (Ki 14.7 μM) and an uncompetitive inhibition with respect to mannose-1-P (Ki 115 μM) .
More Information
Supplier Page
CSNpharm
GDP-α-D-mannose disodium is the donor substrate for mannosyltransferases and the precursor of GDP-β-L-fucose. GDP-α-D-mannose disodium gives a competitive inhibition with respect to GTP (Ki 14.7 μM) and an uncompetitive inhibition with respect to mannose-1-P (Ki 115 μM) .
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Gefarnate has been investigated for the treatment and prevention of stomach ulcer, duodenal ulcer, cardio-cerebrovascular disease and dry eye syndrome.
More Information
Supplier Page
CSNpharm
Gefarnate has been investigated for the treatment and prevention of stomach ulcer, duodenal ulcer, cardio-cerebrovascular disease and dry eye syndrome.
More Information
Supplier Page
CSNpharm
Gefarnate has been investigated for the treatment and prevention of stomach ulcer, duodenal ulcer, cardio-cerebrovascular disease and dry eye syndrome.
More Information
Supplier Page
CSNpharm
Gefitinibis an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively, and interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.
More Information
Supplier Page
CSNpharm
Gefitinibis an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively, and interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.
More Information
Supplier Page
CSNpharm
Gefitinibis an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively, and interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Gelsemine a natural indole alkaloid isolated from flowering plants of the genus Gelsemium with potent activity as an agonist of the mammalian glycine receptor, showing effect on pathways/systems related to xenobiotic- or diet-induced oxidative stress, and in the treatment of anxiety and other conditions.
More Information
Supplier Page
CSNpharm
Gelsemine a natural indole alkaloid isolated from flowering plants of the genus Gelsemium with potent activity as an agonist of the mammalian glycine receptor, showing effect on pathways/systems related to xenobiotic- or diet-induced oxidative stress, and in the treatment of anxiety and other conditions.
More Information
Supplier Page
CSNpharm
Gelsemine a natural indole alkaloid isolated from flowering plants of the genus Gelsemium with potent activity as an agonist of the mammalian glycine receptor, showing effect on pathways/systems related to xenobiotic- or diet-induced oxidative stress, and in the treatment of anxiety and other conditions.
More Information
Supplier Page
CSNpharm
Gelsemine a natural indole alkaloid isolated from flowering plants of the genus Gelsemium with potent activity as an agonist of the mammalian glycine receptor, showing effect on pathways/systems related to xenobiotic- or diet-induced oxidative stress, and in the treatment of anxiety and other conditions.
More Information
Supplier Page
CSNpharm
Gelsemine a natural indole alkaloid isolated from flowering plants of the genus Gelsemium with potent activity as an agonist of the mammalian glycine receptor, showing effect on pathways/systems related to xenobiotic- or diet-induced oxidative stress, and in the treatment of anxiety and other conditions.
More Information
Supplier Page
CSNpharm
Gemcitabine is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively.
More Information
Supplier Page
CSNpharm
Gemcitabine is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively.
More Information
Supplier Page
CSNpharm
Gemcitabine HCl is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively.
More Information
Supplier Page
CSNpharm
Gemcitabine HCl is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively.
More Information
Supplier Page
CSNpharm
Gemcitabine HCl is a DNA synthesis inhibitor with IC50 of 50 nM, 40 nM, 18 nM and 12 nM in PANC1, MIAPaCa2, BxPC3 and Capan2 cells, respectively.
More Information
Supplier Page
CSNpharm
Gemfibrozil is an agonist of PPARα. It can act as a hyperlipidemic agent that elevates plasma HDL and lowers triglycerides.
More Information
Supplier Page
CSNpharm
Gemifloxacin mesylate is an oral broad-spectrum quinolone antibacterial agent, used in the treatment of acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate pneumonia.
More Information
Supplier Page
CSNpharm
Gemifloxacin mesylate is an oral broad-spectrum quinolone antibacterial agent, used in the treatment of acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate pneumonia.
More Information
Supplier Page
CSNpharm
Gemifloxacin mesylate is an oral broad-spectrum quinolone antibacterial agent, used in the treatment of acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate pneumonia.
More Information
Supplier Page
CSNpharm
Gemifloxacin mesylate is an oral broad-spectrum quinolone antibacterial agent, used in the treatment of acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate pneumonia.
More Information
Supplier Page
